Cargando…

Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems

Many infections favor or are directly implicated with lipid metabolism perturbations and/or increased risk of coronary heart disease (CHD). HIV itself has been shown to increase lipogenesis in the liver and to alter the lipid profile, while the presence of unsafe habits, addiction, comorbidities, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melzi, Sara, Carenzi, Laura, Cossu, Maria Vittoria, Passerini, Simone, Capetti, Amedeo, Rizzardini, Giuliano
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065849/ https://www.ncbi.nlm.nih.gov/pubmed/21490912 http://dx.doi.org/10.1155/2010/271504

Ejemplares similares

Short‐term inhibition of SARS‐CoV‐2 by hydrogen peroxide in persistent nasopharyngeal carriers
por: Capetti, Amedeo F., et al.
Publicado: (2020)

Strategic use of dual regimens of boosted protease inhibitors plus maraviroc in poorly adherent subjects in view of long-acting drugs: A retrospective study
por: Capetti, Amedeo Ferdinando, et al.
Publicado: (2017)

Persistence of Long-COVID symptoms in a heterogenous prospective cohort
por: Mariani, Chiara, et al.
Publicado: (2022)

Changes in Lipid Indices in HIV+ Cases on HAART
por: Ji, Shujing, et al.
Publicado: (2019)

Is Dolutegravir Plus Atazanavir Overburdened With Concentration-Related Neurological Events Compared With Other Dual Regimens?
por: Capetti, Amedeo F, et al.
Publicado: (2019)

Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort
por: Capetti, Amedeo F., et al.
Publicado: (2016)

Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy
por: Rizzardini, Giuliano, et al.
Publicado: (2012)

Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study
por: Borgonovo, Fabio, et al.
Publicado: (2021)

One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG
por: Capetti, Amedeo F., et al.
Publicado: (2021)

Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects
por: Borgonovo, Fabio, et al.
Publicado: (2022)

Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort
por: Tontodonati, Monica, et al.
Publicado: (2014)

Risk Factors of Cardiovascular Diseases in HIV/AIDS Patients on HAART
por: Nsagha, Dickson Shey, et al.
Publicado: (2015)

Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers
por: Cossu, Maria Vittoria, et al.
Publicado: (2014)

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks’ observational data
por: Capetti, Amedeo F., et al.
Publicado: (2017)

HIV and HAART-Associated Dyslipidemia
por: Feeney, Eoin R, et al.
Publicado: (2011)

96 Week Follow-Up of HIV-Infected Patients in Rescue with Raltegravir Plus Optimized Backbone Regimens: A Multicentre Italian Experience
por: Capetti, Amedeo, et al.
Publicado: (2012)

Treatment discontinuation in HIV-1-infected individuals starting their first-line HAART after 2008: data from the ICONA Foundation Study Cohort
por: Di Biagio, Antonio, et al.
Publicado: (2014)

HIV/HAART and the brain — what's going on?
por: Portegies, P
Publicado: (2010)

Premature and accelerated aging: HIV or HAART?
por: Smith, Reuben L., et al.
Publicado: (2013)

Gastric Ulcer as Presentation of HIV-Associated Kaposi Sarcoma and Resolution With HAART Therapy
por: Nassri, Rama, et al.
Publicado: (2019)

Oral lesions among HIV seropositive individuals in an era of generic HAART: markers of HAART efficacy?
por: Vasudevan, Janani, et al.
Publicado: (2012)

Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile?
por: Rizzardini, Giuliano, et al.
Publicado: (2012)

Maraviroc Reduces Arterial Stiffness in PI-Treated HIV-infected Patients
por: Piconi, Stefania, et al.
Publicado: (2016)

HAART and ATT in the HIV-positive patient with tuberculosis
por: Jhiens, Zi Z., et al.
Publicado: (2012)

The Pathophysiology of HIV-/HAART-Related Metabolic Syndrome Leading to Cardiovascular Disorders: The Emerging Role of Adipokines
por: Palios, John, et al.
Publicado: (2012)

Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART
por: Rusconi, S, et al.
Publicado: (2010)

Neurocognitive deficits in HIV/AIDS patients on HAART Regime
por: Kumar, Kalagi Amit
Publicado: (2022)

Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: a cross sectional study
por: Fekene, Tamirat Edie, et al.
Publicado: (2018)

Nephrotoxicity of HAART
por: Kalyesubula, Robert, et al.
Publicado: (2011)

Changes in Lipid Profiles and Other Biochemical Parameters in HIV-1 Infected Patients Newly Commenced on HAART Regimen
por: Denue, Ballah Akawu, et al.
Publicado: (2013)

Trends in human papillomavirus (HPV) infection among HIV-positive women in the pre-HAART and HAART era in a Nigerian clinic
por: Onigbogi, MO, et al.
Publicado: (2010)

Anemia and Risk Factors in HAART Naïve and HAART Experienced HIV Positive Persons in South West Ethiopia: A Comparative Study
por: Gedefaw, Lealem, et al.
Publicado: (2013)

Invariant Natural Killer T (iNKT) Cells in HAART-Treated, HIV-Positive Patients with Bone and Cardiovascular Impairment
por: Tincati, Camilla, et al.
Publicado: (2014)

HIV-1 infection in dendritic cells in HAART suppressed patients
por: Maldonado, lrvin M, et al.
Publicado: (2006)

Mesenteric fat thickness in a group of HIV patients on HAART
por: Lee, SS, et al.
Publicado: (2010)

Emergency department utilization by HIV-positive adults in the HAART era
por: Venkat, Arvind, et al.
Publicado: (2008)

Effect of anemia on hepatotoxicity of HAART in HIV patients in Benin city
por: Ugiagbe, Rose A., et al.
Publicado: (2011)

The Impact of HIV on Maternal Morbidity in the Pre-HAART Era in Uganda
por: Nuwagaba-Biribonwoha, Harriet, et al.
Publicado: (2012)

Intensive Care Usage by HIV-Positive Patients in the HAART Era
por: Turtle, L., et al.
Publicado: (2011)

Characteristic of HIV/AIDS infected patients at the detection and HAART initiation
por: Holban, Tiberiu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a551t3j7v6sq6uqe7uta7l4cqh